Jane Street Group, LLC Cure Vac N.V. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$14.73 - $35.25 $42,717 - $102,225	2,900 Added 4.1%	73,600 $1.43 Million
Q4 2021 Feb 15, 2022	SELL	$33.72 - $48.22 $566,496 - $810,096	-16,800 Reduced 19.2%	70,700 $2.44 Million
Q3 2021 Nov 16, 2021	SELL	$49.26 - $74.5 $6.82 Million - $10.3 Million	-138,400 Reduced 61.27%	87,500 $4.79 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $10 Million - $22.4 Million	175,700 Added 350.0%	225,900 $16.6 Million
Q1 2021 May 18, 2021	SELL	$79.79 - $126.29 $1.91 Million - $3.02 Million	-23,900 Reduced 32.25%	50,200 $4.59 Million
Q4 2020 Feb 17, 2021	BUY	$46.76 - $136.27 $3.46 Million - $10.1 Million	74,100 New	74,100 $6.01 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.